Cytovale is a startup based in the United States, 2 tracked investors.
Cytovale is a company founded in 2016 headquartered in the United States. Brouky records 2 investors associated with the company.
Cytovale develops rapid blood-based diagnostic tests for critical care, focusing on identifying sepsis and other acute conditions by measuring immune cell responses at the single-cell level using advanced cytometry and microfluidics technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.